Summary
Previous research suggests that catheter-based renal artery denervation (RDN) reduces blood pressure in patients with resistant hypertension. This article presents the results of the Renal Denervation in Patients With Uncontrolled Hypertension trial [SYMPLICITY HTN-3; Bhatt DL et al. N Engl J Med 2014]. This was a large, prospective, randomized, blinded sham-controlled study conducted to assess the safety and efficacy of percutaneous RDN in patients with resistant hypertension.
- Interventional Radiology
- Hypertension & Kidney Disease
- Renal Disease
- Hypertensive Disease
- Cardiology Clinical Trials
- Interventional Radiology
- Cardiology & Cardiovascular Medicine
- Hypertension & Kidney Disease
- Renal Disease
- Hypertensive Disease
- Cardiology Clinical Trials
- © 2014 MD Conference Express®
Tools
SYMPLICITY HTN-3 Trial: No Blood Pressure Reduction in Patients with Resistant Hypertension Treated with Renal Denervation
Permalink:
Table of contents
Cited By...
- No citing articles found.